Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine after acute stroke
ACTRN12611000774921Phase 3Terminated
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in stroke comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Functional outcome by simplified modified Rankin Scale questionnaire. Started Jan 2013; status: terminated.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on ACTRN12611000774921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000774921.